If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,386.00    58.00 (1.34%)
Bid:
4,382.00
Ask:
4,388.00
Spread: 6.00 (0.137%)
Market Cap: £4.60b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

H1 2020 Trading Statement

22 Jul 2020 07:00

RNS Number : 6872T
Computacenter PLC
22 July 2020
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSE OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) No. 596/2014.

 

FOR IMMEDIATE RELEASE

Computacenter plc

Trading Update - 22nd July 2020

Computacenter plc ("Computacenter" or the "Group"), a leading independent technology partner trusted by large corporate and public sector organisations, today publishes a trading update, based on unaudited financial information, for the period to 30 June 2020.

The Group's adjusted profit before tax in the first half of 2020 has turned out to be substantially ahead of the same period last year.

Whilst most of our industrial clients have been quiet, elsewhere there has been a surge in demand for IT equipment to enable home working which has considerably helped our performance, but this is only part of the story. Computacenter's customers have turned to our Services offerings and the skills of our people at what has been a challenging and demanding time for corporate IT functions. This is testament to the strength of our customer base; the relationships we have with those customers; and the value we deliver to them.

A reforecast of the second half of the year has been reviewed by the Board, which included the first confirmation that the Group's expected adjusted profitability in the second half of the year should be much improved on the forecast considered at the time of our Q1 2020 Trading Update on 23 April. This reforecast has provided better insight and improved clarity for the Board and, coupled with the very pleasing first half result, indicates a reduction in uncertainty in our markets for the second half of 2020. This allows the Board to provide meaningful guidance at this time concerning the second half of the year, notwithstanding the ongoing, and unpredictable, COVID-19 crisis.

Whilst for obvious reasons 2020 is a difficult year to predict, given the performance of the first half, which is behind us, the demand for our Services, the current Managed Services opportunity pipeline and the strength of our customer base, the Board believe that 2020, as a whole, will be a year of material progress for Computacenter, following a record-breaking 2019.

Computacenter's Board acknowledge, as is the case every year, that there is still a significant amount to do in the second half of the year and we look forward to giving more detail at the announcement of the Group's Interim Results on Wednesday 9 September 2020.

Enquiries:

Computacenter plc

Mike Norris, Chief Executive

+44 1707 631601

Tony Conophy, Finance Director

+44 1707 631515

Tulchan Communications

James Macey White

+44 20 7353 4200

Matt Low

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUMCMUPUPUG
Date   Source Headline
1st Aug 20246:03 pmRNSTransaction in Own Shares
1st Aug 202412:00 pmRNSTotal Voting Rights
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
31st Jul 20246:21 pmRNSTransaction in Own Shares
30th Jul 20246:22 pmRNSTransaction in Own Shares
30th Jul 202410:15 amRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:10 amRNSShare Buyback Programme – 26 July 2024
26th Jul 20247:00 amRNSTrading Update and Return of Value – 26 July 2024
2nd Jul 202410:00 amRNSDirectorate Change -Confirmation of Effective Date
5th Jun 20247:00 amRNSCapital Markets Day
14th May 20242:00 pmRNSResult of AGM
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.